Kautzky-Willer A, Bancher-Todesca D, Weitgasser R, Prikoszovich T, Steiner H, Shnawa N, Schernthaner G, Birnbacher R, Schneider B, Marth Ch, Roden M, Lechleitner M
Department of Endocrinology and Metabolism, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, Austria.
J Clin Endocrinol Metab. 2008 May;93(5):1689-95. doi: 10.1210/jc.2007-2301. Epub 2008 Feb 19.
In the face of the ongoing discussion on the criteria for the diagnosis of gestational diabetes (GDM), we aimed to examine whether the criteria of the Fourth International Workshop Conference of GDM (WC) select women and children at risk better than the World Health Organization (WHO) criteria.
This was a prospective longitudinal open study in five tertiary care centers in Austria.
The impact of risk factors, different thresholds (WC vs. WHO), and numbers of abnormal glucose values (WC) during the 2-h, 75-g oral glucose tolerance test on fetal/neonatal complications and maternal postpartum glucose tolerance was studied in 1466 pregnant women. Women were treated if at least one value according to the WC (GDM-WC1) was met or exceeded.
Forty-six percent of all women had GDM-WC1, whereas 29% had GDM-WHO, and 21% of all women had two or three abnormal values according to WC criteria (GDM-WC2). Eighty-five percent of the GDM-WHO were also identified by GDM-WC1. Previous GDM [odds ratio (OR) 2.9], glucosuria (OR 2.4), preconceptual overweight/obesity (OR 2.3), age 30 yr or older (OR 1.9), and large-for-gestational age (LGA) fetus (OR 1.8) were the best independent predictors of the occurrence of GDM. Previous GDM (OR 4.4) and overweight/obesity (OR 4.0) also independently predicted diabetes postpartum. GDM-WC1 had a higher rate of obstetrical complications (LGA neonates, neonatal hypoglycemia, cesarean sections; P < 0.001) and impaired postpartum glucose tolerance (P < 0.0001) than GDM-WHO.
These results suggest the use of more stringent WC criteria for the diagnosis of GDM with the initiation of therapy in case of one fasting or stimulated abnormal glucose value because these criteria detected more LGA neonates with hypoglycemia and mothers with impaired postpartum glucose metabolism than the WHO criteria.
鉴于目前关于妊娠期糖尿病(GDM)诊断标准的讨论,我们旨在研究第四届国际GDM研讨会(WC)的标准在筛选高危妇女和儿童方面是否优于世界卫生组织(WHO)的标准。
这是一项在奥地利五个三级医疗中心进行的前瞻性纵向开放性研究。
在1466名孕妇中,研究了2小时75克口服葡萄糖耐量试验期间危险因素、不同阈值(WC与WHO)以及血糖异常值数量(WC)对胎儿/新生儿并发症和产妇产后糖耐量的影响。若至少有一个值符合或超过WC标准(GDM-WC1),则对妇女进行治疗。
所有妇女中46%患有GDM-WC1,而29%患有GDM-WHO,根据WC标准,21%的妇女有两个或三个异常值(GDM-WC2)。GDM-WC1识别出了85%的GDM-WHO患者。既往GDM(优势比[OR]2.9)、糖尿(OR 2.4)、孕前超重/肥胖(OR 2.3)、30岁及以上年龄(OR 1.9)和大于胎龄(LGA)胎儿(OR 1.8)是GDM发生的最佳独立预测因素。既往GDM(OR 4.4)和超重/肥胖(OR 4.0)也独立预测产后糖尿病。与GDM-WHO相比,GDM-WC1的产科并发症发生率(LGA新生儿、新生儿低血糖、剖宫产;P<;0.001)和产后糖耐量受损发生率(P<;0.0001)更高。
这些结果表明,对于GDM的诊断采用更严格的WC标准,并在出现一次空腹或刺激后血糖异常值时开始治疗,因为与WHO标准相比,这些标准能检测出更多患有低血糖的LGA新生儿和产后糖代谢受损的母亲。